• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮针状筋膜切开术治疗原发性掌腱膜挛缩症

Percutaneous needle fasciotomy for primary Dupuytren's contracture.

作者信息

Rahr L, Søndergaard P, Bisgaard T, Baad-Hansen T

机构信息

Department of Orthopaedic Surgery, Silkeborg Regions Hospital, Denmark.

出版信息

J Hand Surg Eur Vol. 2011 Sep;36(7):548-52. doi: 10.1177/1753193411407245. Epub 2011 May 18.

DOI:10.1177/1753193411407245
PMID:21593073
Abstract

This study evaluated the effect of percutaneous needle fasciotomy on primary Dupuytren's contracture in 149 patients (213 rays) admitted to our clinic in 2007. Ninety-two patients (130 rays) were followed up for 2 years to compare the change in total passive extension deficit and the passive extension deficit across the individual joint and to note side effects. No tendon rupture or damage to sensory nerves was observed and the rehabilitation period was short (mean, 0.6 days). We found a significant change (p < 0.001) in total passive extension deficit after 2 years, but the effect of the treatment was greater in Tubiana I and II stages and our best results were in correction of MCP joint contractures. Percutaneous needle fasciotomy is an alternative treatment for elderly patients with severe comorbidity or for those patients who do not want open surgery.

摘要

本研究评估了经皮针状筋膜切开术对2007年入住我院的149例(213条射线)原发性杜普伊特伦挛缩症患者的疗效。对92例患者(130条射线)进行了2年的随访,以比较总被动伸展缺损的变化以及各个关节的被动伸展缺损,并记录副作用。未观察到肌腱断裂或感觉神经损伤,康复期短(平均0.6天)。我们发现2年后总被动伸展缺损有显著变化(p < 0.001),但在图比阿纳I期和II期治疗效果更佳,我们的最佳结果是矫正掌指关节挛缩。经皮针状筋膜切开术是老年重症合并症患者或不愿接受开放手术患者的一种替代治疗方法。

相似文献

1
Percutaneous needle fasciotomy for primary Dupuytren's contracture.经皮针状筋膜切开术治疗原发性掌腱膜挛缩症
J Hand Surg Eur Vol. 2011 Sep;36(7):548-52. doi: 10.1177/1753193411407245. Epub 2011 May 18.
2
Percutaneous needle fasciotomy in dupuytren's disease.杜普伊特伦挛缩症的经皮针状筋膜切开术
J Hand Surg Br. 2006 Oct;31(5):498-501. doi: 10.1016/j.jhsb.2006.03.174. Epub 2006 Jun 12.
3
Dupuytren's contracture: an analysis of outcomes of percutaneous needle fasciotomy versus open fasciectomy.杜普伊特伦挛缩症:经皮针状筋膜切开术与开放性筋膜切除术的疗效分析
ANZ J Surg. 2015 Sep;85(9):639-43. doi: 10.1111/ans.12513. Epub 2014 Jan 20.
4
Percutaneous needle fasciotomy in Dupuytren's contracture: is it a viable technique?
Acta Orthop Belg. 2012 Feb;78(1):30-4.
5
One-year results of needle fasciotomy and collagenase injection in treatment of Dupuytren's contracture: A two-centre prospective randomized clinical trial.针式筋膜切开术与胶原酶注射治疗掌腱膜挛缩症的一年期结果:一项双中心前瞻性随机临床试验
J Hand Surg Eur Vol. 2016 Jul;41(6):577-82. doi: 10.1177/1753193415617385. Epub 2015 Dec 1.
6
A feasibility study investigating the acceptability and design of a multicentre randomised controlled trial of needle fasciotomy versus limited fasciectomy for the treatment of Dupuytren's contractures of the fingers (HAND-1): study protocol for a randomised controlled trial.一项关于针状筋膜切开术与有限筋膜切除术治疗手指掌腱膜挛缩症的多中心随机对照试验的可接受性和设计的可行性研究(HAND-1):一项随机对照试验的研究方案
Trials. 2017 Aug 25;18(1):392. doi: 10.1186/s13063-017-2127-9.
7
Analysis of recurrence and complications after percutaneous needle fasciotomy in Dupuytren's disease.掌腱膜挛缩症经皮针刀松解术后复发及并发症分析。
Arch Orthop Trauma Surg. 2019 Oct;139(10):1471-1477. doi: 10.1007/s00402-019-03247-y. Epub 2019 Jul 31.
8
A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: a 6-week follow-up study.经皮针状筋膜切开术与局限性筋膜切除术治疗掌腱膜挛缩症的直接疗效比较:一项为期6周的随访研究。
J Hand Surg Am. 2006 May-Jun;31(5):717-25. doi: 10.1016/j.jhsa.2006.02.021.
9
Needle fasciotomy for Dupuytren's contracture- a prospective cohort study of 58 fingers with a median follow-up of 6.5 years.针刀治疗掌腱膜挛缩症- 58 指前瞻性队列研究,中位随访 6.5 年。
J Plast Surg Hand Surg. 2020 Apr;54(2):89-93. doi: 10.1080/2000656X.2019.1693391. Epub 2019 Nov 22.
10
Five-year results of a randomized clinical trial on treatment in Dupuytren's disease: percutaneous needle fasciotomy versus limited fasciectomy.一项关于掌腱膜挛缩病治疗的随机临床试验的 5 年结果:经皮针刀松解与有限筋膜切开术。
Plast Reconstr Surg. 2012 Feb;129(2):469-477. doi: 10.1097/PRS.0b013e31823aea95.

引用本文的文献

1
Collagenase Versus Needle Fasciotomy for Primary Metacarpophalangeal Dupuytren Contracture: Five-Year Results from a Randomized Controlled Trial.胶原酶与经皮针式筋膜切开术治疗原发性掌指关节杜普伊特伦挛缩症:一项随机对照试验的五年结果
JB JS Open Access. 2024 Nov 20;9(4). doi: 10.2106/JBJS.OA.24.00038. eCollection 2024 Oct-Dec.
2
Percutaneous needle fasciotomy in Dupuytren contracture: a register-based, observational cohort study on complications in 3,331 treated fingers in 2,257 patients.经皮针刀筋膜切开术治疗杜普伊特伦挛缩:一项基于登记的、观察性队列研究,涉及 2257 例患者的 3331 个治疗手指的并发症。
Acta Orthop. 2020 Jun;91(3):326-330. doi: 10.1080/17453674.2020.1726057. Epub 2020 Feb 14.
3
The use of Collagenase Clostridium Histolyticum in the management of Dupuytren's contracture-outcomes of a pilot study in a District General Hospital setting.
溶组织梭状芽孢杆菌胶原酶在治疗掌腱膜挛缩症中的应用——一家区综合医院的初步研究结果
Ulster Med J. 2017 May;86(2):94-98. Epub 2017 May 20.
4
What are we measuring? A critique of range of motion methods currently in use for Dupuytren's disease and recommendations for practice.我们在测量什么?对目前用于杜普伊特伦挛缩症的活动度测量方法的批判及实践建议。
BMC Musculoskelet Disord. 2016 Jan 13;17:20. doi: 10.1186/s12891-016-0884-3.
5
Dupuytren's disease: current state of the art.杜普伊特伦挛缩病:当前的技术水平
Hand (N Y). 2014 Mar;9(1):1-8. doi: 10.1007/s11552-013-9563-0.
6
Collagenase clostridium histolyticum in patients with Dupuytren's contracture: results from POINT X, an open-label study of clinical and patient-reported outcomes.溶组织梭状芽孢杆菌胶原酶治疗掌腱膜挛缩症患者:POINT X开放标签临床及患者报告结局研究结果
J Hand Surg Eur Vol. 2015 Feb;40(2):124-32. doi: 10.1177/1753193413519926. Epub 2014 Jan 26.
7
Optimal functional outcome measures for assessing treatment for Dupuytren's disease: a systematic review and recommendations for future practice.评估治疗杜普伊特伦挛缩病的最佳功能结局测量指标:系统评价及对未来实践的建议。
BMC Musculoskelet Disord. 2013 Apr 10;14:131. doi: 10.1186/1471-2474-14-131.